Progesterone and ovulation across stages of the transition to menopause

Kathleen A. O'Connor, Rebecca Ferrell, Eleanor Brindle, Benjamin Trumble, Jane Shofer, Darryl J. Holman, Maxine Weinstein

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Objective: Detailed characterization of progesterone and ovulation across the menopausal transition provides insight into conception risk and mechanisms of reproductive aging. Methods: Participants (n = 108, aged 25-58 y) collected daily urine specimens for 6-month intervals in each of 5 consecutive years. Specimens were assayed for pregnanediol glucuronide (PDG), luteinizing hormone (LH), folliclestimulating hormone (FSH), and estrone glucuronide (ElG). Reproductive stage was determined using cycle length variance. A hierarchical algorithm was used to identify ovulation. Linear mixed-effects models estimated (1) the frequency and day of ovulation by age and stage; (2) differences in FSH, LH, and E1G levels between ovulatory (O) and anovulatory (AO) cycles; and (3) total PDG levels and PDG levels in O cycles by age and stage. Results: The probability of AO cycles increased across the perimenopause (P < 0.0001); reproductive stage was a stronger predictor than age of the probability of anovulation. Most cycles in late perimenopause were AO (>60%), but one quarter of cycles longer than 60 days were O. Average day of ovulation was later in the late perimenopause (mean [SD] cycle day, 27 [25] d) compared with the premenopause. FSH and LH levels were higher and E1G levels were lower in AO than O cycles (P < 0.0001 for each). Total PDG decreased in the late perimenopause, but 95th percentile PDG in O cycles declined steadily across the transition. Conclusions: Exposure to the risk of conception in women experiencing cycles long enough to classify them as late perimenopausal is far from negligible. Reproductive stage is more informative than age about PDG levels and the likelihood of anovulation.

Original languageEnglish (US)
Pages (from-to)1178-1187
Number of pages10
JournalMenopause
Volume16
Issue number6
DOIs
StatePublished - Nov 2009
Externally publishedYes

Fingerprint

Pregnanediol
Glucuronides
Menopause
Ovulation
Progesterone
Perimenopause
Luteinizing Hormone
Hormones
Premenopause
Anovulation
Estrone
Urine

Keywords

  • Anovulation
  • Estrone glucuronide -
  • Follicle-stimulating hormone
  • Luteinizing hormone
  • Menopause
  • Perimenopause
  • Pregnanediol glucuronide
  • Reproductive aging reproductive stage
  • Urinary hormones

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

O'Connor, K. A., Ferrell, R., Brindle, E., Trumble, B., Shofer, J., Holman, D. J., & Weinstein, M. (2009). Progesterone and ovulation across stages of the transition to menopause. Menopause, 16(6), 1178-1187. https://doi.org/10.1097/gme.0b013e3181aa192d

Progesterone and ovulation across stages of the transition to menopause. / O'Connor, Kathleen A.; Ferrell, Rebecca; Brindle, Eleanor; Trumble, Benjamin; Shofer, Jane; Holman, Darryl J.; Weinstein, Maxine.

In: Menopause, Vol. 16, No. 6, 11.2009, p. 1178-1187.

Research output: Contribution to journalArticle

O'Connor, KA, Ferrell, R, Brindle, E, Trumble, B, Shofer, J, Holman, DJ & Weinstein, M 2009, 'Progesterone and ovulation across stages of the transition to menopause', Menopause, vol. 16, no. 6, pp. 1178-1187. https://doi.org/10.1097/gme.0b013e3181aa192d
O'Connor KA, Ferrell R, Brindle E, Trumble B, Shofer J, Holman DJ et al. Progesterone and ovulation across stages of the transition to menopause. Menopause. 2009 Nov;16(6):1178-1187. https://doi.org/10.1097/gme.0b013e3181aa192d
O'Connor, Kathleen A. ; Ferrell, Rebecca ; Brindle, Eleanor ; Trumble, Benjamin ; Shofer, Jane ; Holman, Darryl J. ; Weinstein, Maxine. / Progesterone and ovulation across stages of the transition to menopause. In: Menopause. 2009 ; Vol. 16, No. 6. pp. 1178-1187.
@article{2755c4c987774f4297bce4806916943c,
title = "Progesterone and ovulation across stages of the transition to menopause",
abstract = "Objective: Detailed characterization of progesterone and ovulation across the menopausal transition provides insight into conception risk and mechanisms of reproductive aging. Methods: Participants (n = 108, aged 25-58 y) collected daily urine specimens for 6-month intervals in each of 5 consecutive years. Specimens were assayed for pregnanediol glucuronide (PDG), luteinizing hormone (LH), folliclestimulating hormone (FSH), and estrone glucuronide (ElG). Reproductive stage was determined using cycle length variance. A hierarchical algorithm was used to identify ovulation. Linear mixed-effects models estimated (1) the frequency and day of ovulation by age and stage; (2) differences in FSH, LH, and E1G levels between ovulatory (O) and anovulatory (AO) cycles; and (3) total PDG levels and PDG levels in O cycles by age and stage. Results: The probability of AO cycles increased across the perimenopause (P < 0.0001); reproductive stage was a stronger predictor than age of the probability of anovulation. Most cycles in late perimenopause were AO (>60{\%}), but one quarter of cycles longer than 60 days were O. Average day of ovulation was later in the late perimenopause (mean [SD] cycle day, 27 [25] d) compared with the premenopause. FSH and LH levels were higher and E1G levels were lower in AO than O cycles (P < 0.0001 for each). Total PDG decreased in the late perimenopause, but 95th percentile PDG in O cycles declined steadily across the transition. Conclusions: Exposure to the risk of conception in women experiencing cycles long enough to classify them as late perimenopausal is far from negligible. Reproductive stage is more informative than age about PDG levels and the likelihood of anovulation.",
keywords = "Anovulation, Estrone glucuronide -, Follicle-stimulating hormone, Luteinizing hormone, Menopause, Perimenopause, Pregnanediol glucuronide, Reproductive aging reproductive stage, Urinary hormones",
author = "O'Connor, {Kathleen A.} and Rebecca Ferrell and Eleanor Brindle and Benjamin Trumble and Jane Shofer and Holman, {Darryl J.} and Maxine Weinstein",
year = "2009",
month = "11",
doi = "10.1097/gme.0b013e3181aa192d",
language = "English (US)",
volume = "16",
pages = "1178--1187",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Progesterone and ovulation across stages of the transition to menopause

AU - O'Connor, Kathleen A.

AU - Ferrell, Rebecca

AU - Brindle, Eleanor

AU - Trumble, Benjamin

AU - Shofer, Jane

AU - Holman, Darryl J.

AU - Weinstein, Maxine

PY - 2009/11

Y1 - 2009/11

N2 - Objective: Detailed characterization of progesterone and ovulation across the menopausal transition provides insight into conception risk and mechanisms of reproductive aging. Methods: Participants (n = 108, aged 25-58 y) collected daily urine specimens for 6-month intervals in each of 5 consecutive years. Specimens were assayed for pregnanediol glucuronide (PDG), luteinizing hormone (LH), folliclestimulating hormone (FSH), and estrone glucuronide (ElG). Reproductive stage was determined using cycle length variance. A hierarchical algorithm was used to identify ovulation. Linear mixed-effects models estimated (1) the frequency and day of ovulation by age and stage; (2) differences in FSH, LH, and E1G levels between ovulatory (O) and anovulatory (AO) cycles; and (3) total PDG levels and PDG levels in O cycles by age and stage. Results: The probability of AO cycles increased across the perimenopause (P < 0.0001); reproductive stage was a stronger predictor than age of the probability of anovulation. Most cycles in late perimenopause were AO (>60%), but one quarter of cycles longer than 60 days were O. Average day of ovulation was later in the late perimenopause (mean [SD] cycle day, 27 [25] d) compared with the premenopause. FSH and LH levels were higher and E1G levels were lower in AO than O cycles (P < 0.0001 for each). Total PDG decreased in the late perimenopause, but 95th percentile PDG in O cycles declined steadily across the transition. Conclusions: Exposure to the risk of conception in women experiencing cycles long enough to classify them as late perimenopausal is far from negligible. Reproductive stage is more informative than age about PDG levels and the likelihood of anovulation.

AB - Objective: Detailed characterization of progesterone and ovulation across the menopausal transition provides insight into conception risk and mechanisms of reproductive aging. Methods: Participants (n = 108, aged 25-58 y) collected daily urine specimens for 6-month intervals in each of 5 consecutive years. Specimens were assayed for pregnanediol glucuronide (PDG), luteinizing hormone (LH), folliclestimulating hormone (FSH), and estrone glucuronide (ElG). Reproductive stage was determined using cycle length variance. A hierarchical algorithm was used to identify ovulation. Linear mixed-effects models estimated (1) the frequency and day of ovulation by age and stage; (2) differences in FSH, LH, and E1G levels between ovulatory (O) and anovulatory (AO) cycles; and (3) total PDG levels and PDG levels in O cycles by age and stage. Results: The probability of AO cycles increased across the perimenopause (P < 0.0001); reproductive stage was a stronger predictor than age of the probability of anovulation. Most cycles in late perimenopause were AO (>60%), but one quarter of cycles longer than 60 days were O. Average day of ovulation was later in the late perimenopause (mean [SD] cycle day, 27 [25] d) compared with the premenopause. FSH and LH levels were higher and E1G levels were lower in AO than O cycles (P < 0.0001 for each). Total PDG decreased in the late perimenopause, but 95th percentile PDG in O cycles declined steadily across the transition. Conclusions: Exposure to the risk of conception in women experiencing cycles long enough to classify them as late perimenopausal is far from negligible. Reproductive stage is more informative than age about PDG levels and the likelihood of anovulation.

KW - Anovulation

KW - Estrone glucuronide -

KW - Follicle-stimulating hormone

KW - Luteinizing hormone

KW - Menopause

KW - Perimenopause

KW - Pregnanediol glucuronide

KW - Reproductive aging reproductive stage

KW - Urinary hormones

UR - http://www.scopus.com/inward/record.url?scp=73249134766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73249134766&partnerID=8YFLogxK

U2 - 10.1097/gme.0b013e3181aa192d

DO - 10.1097/gme.0b013e3181aa192d

M3 - Article

C2 - 19568209

AN - SCOPUS:73249134766

VL - 16

SP - 1178

EP - 1187

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 6

ER -